• (Z)-4-Hydroxytamoxifen: Precision Modulation of Estrogen Sig

  2026-07-27

  (Z)-4-Hydroxytamoxifen is a potent estrogen receptor modulator essential for dissecting estrogen-dependent signaling in preclinical research. This article explores its mechanistic precision, unique antiestrogenic activity, and advanced assay considerations—offering deeper insights and practical guidance beyond conventional protocols.

• Neurotensin: Applied Workflows for GPCR Trafficking Studies

  2026-07-26

  Neurotensin (CAS 39379-15-2) is revolutionizing the study of G protein-coupled receptor signaling and miRNA regulation in gastrointestinal systems. This article delivers actionable workflows, troubleshooting tactics, and comparative insights to help researchers achieve interference-resistant, data-rich results when using this potent Neurotensin receptor 1 activator.

• Aerobic Activation of HIF1α by BCKAs in Vascular Cells: Mech

  2026-07-25

  The referenced study uncovers a novel mechanism by which branched chain α-ketoacids (BCKAs) activate HIF1α signaling in human vascular cells under normoxic conditions, revealing a paracrine metabolite-mediated pathway that modulates vascular smooth muscle cell phenotype. These findings have significant implications for understanding metabolic regulation in vascular pathobiology, especially in pulmonary arterial hypertension.

• TSPAN18 Regulates STIM1 to Promote Bone Metastasis in Prosta

  2026-07-24

  Zhou et al. (2023) identify TSPAN18 as a novel regulator of bone metastasis in prostate cancer, showing that TSPAN18 stabilizes STIM1 by preventing its TRIM32-mediated ubiquitination. This mechanism enhances calcium influx and supports metastatic progression, offering new molecular targets for intervention in hormone-responsive cancer research.

• Iron-Dependent KDM4D Controls MSC Activation via PI3K-Akt-Fo

  2026-07-24

  This study demonstrates that iron-dependent KDM4D histone demethylase activity governs the activation of quiescent mesenchymal stem cells (MSCs) through the PI3K-Akt-Foxo1 pathway. The findings clarify a new epigenetic mechanism for how iron deficiency impairs MSC mobilization and bone remodeling, offering significant implications for osteoporosis and metabolic bone disorder research.

• Palonosetron Hydrochloride for CINV/RINV: Mechanisms and Cli

  2026-07-23

  This article reviews the 2013 update by Fabi & Malaguti on palonosetron hydrochloride, highlighting its distinct pharmacological properties as a 5-HT3 receptor antagonist and its clinical relevance for chemotherapy- and radiotherapy-induced nausea and vomiting. The paper details mechanistic, pharmacokinetic, and guideline-based advances that position palonosetron as a preferred agent for preventing both acute and delayed emesis in oncology settings.

• 2-Thio-dCTP: Precision DNA Modification & Polymerase Assays

  2026-07-23

  2-Thio-dCTP enables targeted, high-fidelity DNA modifications and advanced DNA-protein interaction studies by leveraging sulfur substitution for enhanced polymerase selectivity. This guide details practical workflows, troubleshooting strategies, and recent innovations that empower researchers to explore chromatin regulation and mitotic fidelity with confidence.

• ω-Agatoxin IVA TFA: Precision Tools for Cav2.1 Channel Disco

  2026-07-22

  Explore the mechanistic and translational significance of ω-Agatoxin IVA TFA as a selective Cav2.1 channel inhibitor. This article bridges cutting-edge structural insights with strategic guidance for researchers in synaptic transmission, epilepsy models, and neuroprotection, providing protocol clarity and actionable strategies beyond standard product pages.

• Flavopiridol (L868275): Applied Workflows for Cell Cycle Arr

  2026-07-22

  Flavopiridol (L868275) is a gold-standard cell cycle arrest agent, uniquely enabling robust interrogation of CDK-driven pathways in cancer and stem cell models. This article breaks down practical protocols, troubleshooting, and the latest reference-driven insights for maximizing Flavopiridol’s translational value in advanced cellular research.

• ABT-199 (Venetoclax): Redefining Selective Apoptosis in Canc

  2026-07-21

  Explore how ABT-199 (Venetoclax) enables next-generation apoptosis assay design and targeted cancer research. This article uniquely examines its mechanistic selectivity, senolytic synergy, and pivotal protocol guidance for advanced hematologic and glioblastoma models.

• GRE Combination Suppresses Melanogenesis via CREB/MITF Downr

  2026-07-21

  The referenced study introduces a novel combination of glabridin, resveratrol, and ellagic acid (GRE) that significantly inhibits melanin production, oxidative stress, and inflammation in cellular models. By targeting the CREB/MITF signaling pathway, GRE offers a mechanistically grounded approach to address pigmentation disorders and provides a promising alternative to conventional skin-lightening agents.

• Phosphatase Inhibitor Cocktail 1: Reliable Phosphorylation P

  2026-07-20

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) from APExBIO empowers researchers to achieve robust, reproducible preservation of protein phosphorylation, even in complex tissue and cell lysates. This guide translates recent cardiac remodeling breakthroughs into actionable workflows, troubleshooting insights, and protocol enhancements for high-fidelity phosphoproteomic and signaling studies.

• Jasplakinolide: Precision Actin Polymerization Inducer Workf

  2026-07-20

  Jasplakinolide from APExBIO stands out as a robust actin polymerization inducer, enabling unmatched control over cytoskeletal dynamics in cell biology, imaging, and antifungal research. This guide showcases advanced workflows, troubleshooting strategies, and actionable parameters to drive reproducible results in both cellular and translational contexts.

• Azilsartan Medoxomil in Hypertension: Meta-Analysis Insights

  2026-07-19

  A recent systematic review and meta-analysis rigorously evaluated the efficacy and safety profile of azilsartan medoxomil in managing hypertension, including in patients with comorbid diabetes. The findings confirm superior blood pressure reduction compared to other therapies, with no increased risk of adverse events, reinforcing its role in essential hypertension treatment research.

• N1-Methylpseudouridine Ensures Fidelity in mRNA Vaccine Tran

  2026-07-18

  The reference study rigorously demonstrates that N1-methylpseudouridine, a key modification in COVID-19 mRNA vaccines, preserves the accuracy of protein translation without introducing miscoding. These findings reinforce the value of N1-methylpseudo-UTP for researchers aiming to optimize mRNA therapeutics for stability and translational fidelity.

451 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page